-
Benzinga's Top Upgrades
Thursday, August 4, 2011 - 7:37am | 128Robert W. Baird upgraded Almost Family Inc (NASDAQ: AFAM) from “underperform” to “neutral.” AFAM's shares closed at $21.92 yesterday. Almost Family's PEG ratio is 0.53. Rodman & Renshaw upgraded NxStage Medical Inc (NASDAQ: NXTM) from “market underperform” to “market perform.” NXTM's shares...
-
J.P. Morgan Ups PT On THOR To $38
Thursday, August 4, 2011 - 7:26am | 123J.P. Morgan, in light of strong 2Q numbers from the company, is raising its price target from $32 to $38 on Thoratec (NASDAQ: THOR). In its report, J.P. Morgan writes, “Thoratec reported strong 2Q results Wednesday after the close, with total revenues of $111.2M (+17%) coming in $6.2M above our...
-
Morgan Keegan Maintains Market Perform on Thoratec
Thursday, August 4, 2011 - 7:24am | 87Morgan Keegan is out with its report today on Thoratec (NASDAQ: THOR), maintaining Market Perform. In its report, Morgan Keegan writes, "We are maintaining our Market Perform rating and Price Target of $35. Though the company reported approximately 20% revenue growth in Heartmate sales, strong U.S...
-
Piper Jaffray Reiterates Overweight and PT of $5 on Hansen Medical
Thursday, August 4, 2011 - 6:42am | 48Piper Jaffray reiterated its Overweight rating on Hansen Medical (NASDAQ: HNSN). At the same time, the rating agency left its price target on the company's stock unchanged at $5. On Wednesday, HNSN added 0.73% to its value to finish the day at $4.14.
-
JP Morgan Raises PT On Thoratec To $38
Thursday, August 4, 2011 - 6:39am | 27JP Morgan has raised the price target on Thoratec Corporation (NASDAQ: THOR) from $32 to $38 and maintains its Neutral rating.
-
Bank of America Lowers PO On Hill-Rom Holdings To $39
Thursday, August 4, 2011 - 5:55am | 28Bank of America has lowered the price objective on Hill-Rom Holdings (NYSE: HRC) from $48 to $39 and maintains its Buy rating.
-
Rodman & Renshaw Upgrades NxStage Medical
Wednesday, August 3, 2011 - 5:32pm | 74Rodman & Renshaw upgraded its NxStage (NASDAQ: NXTM) rating to Market Perform in a research report published today. In the report, Rodman & Renshaw states, "We are upgrading our rating to a Market Perform. The stock is close to our PT and given the risks we see on the horizon, is fairly...
-
Covidien Announces First Patient Enrollment in DEFINITIVE AR Study
Wednesday, August 3, 2011 - 4:33pm | 81Covidien (NYSE: COV) today announced the start of patient enrollment in the ev3 DEFINITIVE™ AR (Anti-Restenosis) study Imelda Hospital in Belgium with Dr. Patrick Peeters. DEFINITIVE AR is a European pilot study designed to address the challenge of restenosis (narrowing of a blood vessel) in...
-
Thoratec Announces Acquisition of Medical Business of Levitronix for $110M
Wednesday, August 3, 2011 - 4:30pm | 120Thoratec Corporation (Nasdaq: THOR) entered into an Agreement and Plan of Merger with Levitronix LLC, a Delaware limited liability company, Revere Merger Sub, LLC, a Delaware limited liability company and wholly-owned subsidiary of Thoratec, Pharos, LLC, a Delaware limited liability company,...
-
IVAX Diagnostics Enters into Distribution Agreement with LABSCO
Wednesday, August 3, 2011 - 4:16pm | 134IVAX Diagnostics, Inc. (NYSE: IVD) announced that Diamedix Corporation, IVAX Diagnostics' wholly-owned subsidiary located in Miami, Florida, has signed a three-year agreement with Laboratory Supply Company, the largest privately held supplier of diagnostic instrumentation and clinical laboratory...
-
Intraday Gainers
Wednesday, August 3, 2011 - 3:56pm | 121InterDigital (NASDAQ: IDCC) +13.87 on rumors of Samsung buying company's patent portfolio. NxStage Medical (NASDAQ: NXTM) +12.44% on better than expected earnings. MasterCard (NYSE: MA) +12.98 on better than expected earnings. WebMD Health (NASDAQ: WBMD) +12.10 on better than expected earnings...
-
Rodman & Renshaw Upgrades Insulet
Wednesday, August 3, 2011 - 3:01pm | 80Rodman & Renshaw upgraded its Insulet (NASDAQ: PODD) rating to Market Perform in a research report published today. In the report, Rodman & Renshaw states, "We are upgrading Insulet to a Market Perform rating. Our core concerns of over-enthusiastic Street expectations remain, however, the...
-
Misonix Announces New Distribution Agreement for Taiwan
Wednesday, August 3, 2011 - 8:33am | 90Misonix, Inc. (NASDAQ: MSON) has entered into a new three-year exclusive distribution agreement with Grand Medical Instrument Co., Ltd., based in Taichung, Taiwan, R.O.C., for the distribution of the SonaStar® Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone Cutter. The agreement...
-
Misonix Announces New Distribution Agreement for Taiwan
Wednesday, August 3, 2011 - 8:33am | 124Misonix, Inc. (NASDAQ: MSON) has entered into a new three-year exclusive distribution agreement with Grand Medical Instrument Co., Ltd., based in Taichung, Taiwan, R.O.C., for the distribution of the SonaStar® Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone Cutter. The agreement...
-
EDAP Gains U.S. FDA 510(k) Lithotripter Clearance
Wednesday, August 3, 2011 - 8:30am | 198EDAP TMS SA (Nasdaq: EDAP) announced it has received marketing clearance from the U.S. Food and Drug Administration (FDA) for its Sonolith i-move device, a technologically advanced compact mobile lithotripter. The U.S. FDA has cleared EDAP's Sonolith i-move device for fragmentation of kidney stones...